Medical Device News Magazine

Acutus Medical Secures FDA Clearance and CE Mark for SuperMap™

Announces First Procedures in U.S. and Initial Experience in EU

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Acutus Medical today announced FDA clearance and CE Mark of SuperMap™ – a revolutionary addition to its AcQMap 3D Imaging and Mapping System. SuperMap is a high-fidelity, high-resolution mapping algorithm for both stable and transient arrhythmias. SuperMap’s user interface effortlessly guides electrophysiologists to quickly create exquisitely detailed whole-chamber maps of the left or right atrium using its unique non-contact roving “hover-map” approach.

This allows electrophysiologists to diagnose and treat arrhythmia patients rapidly, consistently and potentially more effective.  Adding the SuperMap mode to the AcQMap system enables users to visualize any atrial rhythm in under three minutes. Rapidly mapping and re-mapping the whole heart chamber facilitates a new procedural workflow in EP ablation — by making it practical to execute an iterative “map, ablate, re-map” approach to diagnosis and therapy.

With this groundbreaking addition, Acutus Medical delivers the only EP imaging and mapping system to offer three mapping modalities: contact mapping, non-contact mapping, and non-contact hover mapping — known as SuperMap.

Initial Experience EU*: “In less than three minutes, the AcQMap System can map the entire chamber to clearly identify re-entrant circuits, regions of slow conduction and focal origins. The Automatic Beat Grouping algorithm of SuperMap is helpful to map alternating or changing atrial tachycardias by categorizing and displaying multiple tachycardias occurring at the same time,” said Dr. Tom Wong, Electrophysiologist, Royal Brompton & Harefield NHS Foundation Trust, London, England.

“Dynamic atrial substrate characterization is an emerging diagnostic strategy involving the mapping of sinus and paced rhythms to identify clinically relevant areas of slow conduction, lines of block and critical zones of irregular activity. These areas may correlate with arrhythmia initiation or maintenance. SuperMap is the ideal tool for implementing this strategy. Within seconds, I can review the maps and identify zones of slow conduction,” said Dr. Gian-Battista Chierchia, Electrophysiologist, Vrije Universiteit Brussel, Brussels, Belgium.

First Cases in the U.S.:  “It is critical to map repetitive rhythms in patients with irregular heartbeats. This approach is extremely helpful in identifying areas of low amplitude which may indicate scar. I am looking forward to integrating new technology into my workflow for the treatment of any arrhythmia,” stated Gregory Feld, MD, Professor of Medicine at UC San Diego School of Medicine and director of the Cardiac Electrophysiology Program at UC San Diego Health.

“We recently completed an extraordinary case with the Acutus system and SuperMap. We captured three whole-chamber maps, targeted three ablation sites, and the patient left in sinus rhythm — all in the span of one hour,” said Arjun Gururaj, MD, Electrophysiologist, Nevada Heart & Vascular Center in Las Vegas, Nevada. “These are notoriously complex atrial tachycardias that the EP community knows about. SuperMap can show potential sources and likely mechanisms in those complex cases in minutes as opposed to hours with conventional systems — because we are seeing things that we couldn’t see before.  Now we may be able to do something about it in far less time with better acute results. It has amazing potential.”

Vince Burgess, President & CEO of Acutus Medical commented, “We have invested heavily in developing a unique, multifunctional mapping system that provides physicians with the visual information needed to effectively diagnose and treat patients. With three distinct and unique mapping modalities in one system, physicians can feel confident in tackling any atrial arrhythmia accurately and efficiently. We are committed to improving patient outcomes, expediting procedures times and further developing our full suite of products for the global electrophysiology community.”

*The AcQMap System with SuperMap was CE Marked in October of 2019.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”